A two-months study performed by Professor P.A. Fedirko, T.F. Babenko, Dr. habil. and R.Yu. Dorichevska. Research Associate, in the Laboratory of Ophthalmology, Radiation Hygiene and Epidemiology Institute of the State Enterprise “National Scientific Centre of Radiation Medicine, National Academy of Medical Sciences of Ukraine”, Kyiv.
The study was performed with the participation of the patients with pronounced retinal angiopathy, who were administered the natural complex Resverasin for two months in dosage of 1 capsule twice a day.
Results of the study have reliably proved an improvement of vision acuity, better microcirculation in the conjunctiva, increase of the retinal artery diameter and absence of side effects. On the basis of the obtained data, the researchers of the Institute recommend natural complex Resverasin® for use in ophthalmological practice, primarily in treatment of the retinal vascular pathology of various genesis – both in combination with other medications and in monotherapy.
The full text of the paper can be found here:
